BIOMEDICA Medizinprodukte GmbH
BIOMEDICA Medizinprodukte GmbH is a Vienna-based, CEE-focused medical device, IVD, and life science distributor operating across 13 countries via 13 subsidiaries, also selling proprietary immunoassays and clinical IT software. It is a wholly-owned subsidiary of Sweden-listed AddLife AB.
- Company typePrivate
- Founded1978
- HeadquartersVienna, Austria
- Headcount101–250
- GTM typeB2B
- OfferingServices
What BIOMEDICA Medizinprodukte GmbH does
BIOMEDICA Medizinprodukte GmbH is a Vienna-headquartered multinational distributor serving the Central and Eastern European (CEE) medtech and diagnostics market through 13 wholly-owned subsidiaries across Austria, the Balkans, Czechia, Hungary, Poland, Romania, Slovakia, Slovenia, and Switzerland. Founded in 1978, the company operates eight divisions covering Medical Devices (cardiac surgery consumables and equipment), In Vitro Diagnostics (reagents, kits, point-of-care and high-throughput systems), Life Sciences (over 1 million SKUs from 200+ international principals), proprietary Biomedica Immunoassays (R&D since 1988 in cardiorenal, osteology, nephrology, and oncology), Clinical IT (patient data management for anesthesia, ICU, IMCU, NICU), Industry Diagnostics (quality control for pharma, food, dairy, cosmetics), and Application & Service (27+ service engineers, 14 application specialists, 5,000+ product installations).
The business monetizes through hardware sales of distributed devices and consumables, plus recurring application support, maintenance contracts, managed Clinical IT services, and custom analytical testing (ELISA, Luminex, NGS, RT-qPCR, microRNA). Biomedica's go-to-market is enterprise field sales: local Managing Directors run country P&Ls while centralized procurement and supplier management sit at the Vienna HQ. Customers are hospitals, clinical centers, hospital and reference laboratories, universities, and pharma/biotech industrial buyers; product availability varies by market.
Since November 2018, BIOMEDICA has been a wholly-owned subsidiary of Sweden-listed AddLife AB, a Medtech/Labtech roll-up. Headcount is reported at ~280 across the group (with conflicting firmographic data citing 152), supported by ISO 9001:2015 (TÜV) and Quality Austria certifications. No revenue figures are publicly disclosed at the subsidiary level.
BIOMEDICA Medizinprodukte GmbH firmographics
Firmographics- Name
- BIOMEDICA Medizinprodukte GmbH
- Legal name
- BIOMEDICA Medizinprodukte GmbH
- Website
- https://bmgrp.eu
- Company type
- Private
- Founded year
- 1978
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- BIOMEDICA Medizinprodukte GmbH is a Vienna-based, CEE-focused medical device, IVD, and life science distributor operating across 13 countries via 13 subsidiaries, also selling proprietary immunoassays and clinical IT software. It is a wholly-owned subsidiary of Sweden-listed AddLife AB.
- Ownership category
- akta.pro rank
BIOMEDICA Medizinprodukte GmbH industry classification
Industry- Product category
- Medical Device Distribution and IVD Services
- NAICS
- Medical Equipment and Supplies Manufacturing (3391), In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
- akta.pro secondary industries
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
Keywords
Where BIOMEDICA Medizinprodukte GmbH is headquartered
LocationHeadquarters
- HQ city
- Vienna
- HQ country
- Austria
- HQ region
- Europe
Offices14 records
Markets served
BIOMEDICA Medizinprodukte GmbH business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Devices Distribution: Distribution of medical devices for cardiac surgery and various hospital departments across Central and Eastern Europe. Products include consumables and equipment for clinical use.
- In Vitro Diagnostics Products and Services: Supply of IVD reagents, test kits, and equipment. Services include installation, validation, maintenance, and on-site training by field experts.
- Life Science Products: Distribution of over 1 million products from international suppliers including research reagents, equipment, lab consumables for academic and industrial research.
- Biomedica Immunoassays: Proprietary immunoassay products for clinical research, sold globally through established distribution network.
- Clinical IT Software Solutions: Custom medical software implementations with 24/7 service helpdesk support.
- Application and Service Support: Technical support including equipment installation, maintenance, repair, product training, and troubleshooting.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
BIOMEDICA Medizinprodukte GmbH product offering
Product offeringCore offering
BIOMEDICA Medizinprodukte GmbH is a multinational distributor of medical devices, in-vitro diagnostics (IVD) products, life science research supplies, and proprietary Biomedica Immunoassays across 13 Central and Eastern European countries. The company operates eight divisions covering medical devices, IVD, life sciences, immunoassays, clinical IT software for hospital departments (ICU/IMCU/NICU/anesthesia), industrial diagnostics, and application/service support. It supplements distribution with installation, validation, training, 24/7 technical support, and custom analytical testing services (ELISA, Luminex, NGS, microRNA).
Product overview
BIOMEDICA Medizinprodukte GmbH is a multinational distributor of medical products operating across Central and Eastern Europe with 8 divisions covering Medical Devices, In Vitro Diagnostics, Life Sciences, Biomedica Immunoassays, Clinical IT, Industry Diagnostics, and Application & Service. The company's core offerings include distribution of medical devices for cardiac surgery, IVD products (reagents, test kits, equipment), over 1 million Life Science products from international suppliers, proprietary Biomedica Immunoassays (R&D since 1988 for cardiology, osteology, nephrology, oncology), Clinical IT software solutions for hospital departments, and analytical/testing services. The company also provides installation, training, and technical support through its Application and Service division. Founded in Vienna in 1978, the company operates 13 subsidiaries across the CEE region.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 27+ service engineers supporting customers
- +3 more outcomes
Companies that use BIOMEDICA Medizinprodukte GmbH
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles5 records
BIOMEDICA Medizinprodukte GmbH technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
BIOMEDICA Medizinprodukte GmbH partnerships and signals
Strategic signalScale indicators14 records
Recent moves15 records
Expansion highlights5 records
BIOMEDICA Medizinprodukte GmbH competitors and assessment
Company assessmentDirect peers
- HVD Life Sciences: A Vienna-based life science distributor serving Central and Eastern Europe with reagents, consumables, and instruments; directly comparable to Biomedica in regional footprint, product mix, and customer base across DACH/CEE labs and research institutions.
- Sarstedt: Manufacturer and distributor of medical devices, specimen containers, and laboratory consumables serving hospitals and diagnostic labs in Europe; overlaps with Biomedica's Medical Devices and Life Sciences divisions on consumables and pre-analytics supply.
- BioNordika: An AddLife AB sister company distributing life science products and instruments across the Nordics and Baltics; mirrors Biomedica's role, supplier network, and go-to-market within the AddLife group, providing a near-clone operational comparison.
- Bio-Rad Laboratories: Life science research and clinical diagnostics manufacturer with a broad IVD, immunoassay, and lab consumables portfolio distributed through European partners; comparable to Biomedica's IVD, immunoassay, and Life Sciences distribution scope.
- DiaSorin: Specialty IVD manufacturer focused on immunoassays for infectious diseases, cardiorenal, and bone metabolism—directly competitive with Biomedica Immunoassays and the IVD distribution product line across CEE hospital and reference-lab customers.
Broad incumbents
- Thermo Fisher Scientific: Largest global life science tools and IVD provider; competes with Biomedica's distribution franchise on instruments, reagents, and consumables, and represents both a competitor and a key supplier principal across CEE.
- Avantor: Global life science products and services distributor (formerly VWR), supplying lab consumables, reagents, and equipment to research and clinical customers; broader scale and geographic reach than Biomedica but overlapping on the Life Sciences product distribution franchise.
- Merck KGaA (Life Science): Global life science tools and reagents supplier via the Sigma-Aldrich portfolio, serving academic, pharma, and clinical customers; the primary principal Biomedica competes with and distributes for in lab reagents across CEE.
- Abbott Diagnostics: Global IVD and clinical chemistry leader with established European direct sales in chemistry, immunoassay, and point-of-care; significant overlap with Biomedica's IVD division and reagent distribution franchise in CEE hospitals.
Emerging players
- Agilent Technologies: Analytical instrument and consumables supplier expanding European life science distribution channels; partial overlap with Biomedica's life science reagents, NGS-adjacent, and analytical instrument portfolio for CEE research customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
BIOMEDICA Medizinprodukte GmbH social profiles
Digital presenceBIOMEDICA Medizinprodukte GmbH compliance and trust
Trust signalCompliance2 records
BIOMEDICA Medizinprodukte GmbH financial estimates
Financial estimateRevenue estimate
Valuation estimate
BIOMEDICA Medizinprodukte GmbH leadership team
Management profileNumber of profiles
Profiles12 records
BIOMEDICA Medizinprodukte GmbH subsidiaries and ownership
Company hierarchySubsidiaries12 records
BIOMEDICA Medizinprodukte GmbH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BIOMEDICA Medizinprodukte GmbH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BIOMEDICA Medizinprodukte GmbH
What does BIOMEDICA Medizinprodukte GmbH do?
BIOMEDICA Medizinprodukte GmbH is a multinational distributor of medical devices, in-vitro diagnostics (IVD) products, life science research supplies, and proprietary Biomedica Immunoassays across 13 Central and Eastern European countries. The company operates eight divisions covering medical devices, IVD, life sciences, immunoassays, clinical IT software for hospital departments (ICU/IMCU/NICU/anesthesia), industrial diagnostics, and application/service support. It supplements distribution with installation, validation, training, 24/7 technical support, and custom analytical testing services (ELISA, Luminex, NGS, microRNA).
Is BIOMEDICA Medizinprodukte GmbH a public or private company?
BIOMEDICA Medizinprodukte GmbH is a private company. It is classified as corporate owned and is currently operating.
When was BIOMEDICA Medizinprodukte GmbH founded?
BIOMEDICA Medizinprodukte GmbH was founded in 1978. It employs 101 to 250 people.
Where is BIOMEDICA Medizinprodukte GmbH based?
BIOMEDICA Medizinprodukte GmbH is headquartered in Vienna, Austria, in the Europe region.
How does BIOMEDICA Medizinprodukte GmbH make money?
Six revenue lines are on record. Medical Devices Distribution is the primary driver. The others are in Vitro Diagnostics Products and Services, life Science Products, biomedica Immunoassays, clinical IT Software Solutions and application and Service Support.
Who are BIOMEDICA Medizinprodukte GmbH's main competitors?
Direct peers on record are HVD Life Sciences, Sarstedt, BioNordika, Bio-Rad Laboratories and DiaSorin. Broad incumbents are Thermo Fisher Scientific, Avantor, Merck KGaA (Life Science) and Abbott Diagnostics. Agilent Technologies is listed as an emerging player.
Does BIOMEDICA Medizinprodukte GmbH have an API?
No public API is recorded for BIOMEDICA Medizinprodukte GmbH.
What industry is BIOMEDICA Medizinprodukte GmbH in?
BIOMEDICA Medizinprodukte GmbH's product category is Medical Device Distribution and IVD Services. Its primary akta.pro industry code is HLAGAMAD, Specialty Pharma & Biologics Distribution (GDP-compliant), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 3391 and its SIC code is 5047.